The American Journal of Managed Care11d
Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs
In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the Medicare $2 drug list model, patient out-of-pocket payments would have totaled ...
Medicare Drug Costs Spike
Out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries ...
American Hospital Association20h
CMS releases final rule for 2026 Medicare Advantage, prescription drug plans
The Centers for Medicare & Medicaid Services April 4 finalized changes to the Medicare Advantage and prescription drug ...
pharmaphorum3d
Ozempic tops new Medicare price negotiation list
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
STAT11d
Net prices for medicines inched up in last year’s fourth quarter after falling a year ago, analysis finds
Net prices that health plans paid for medicines rose a modest 0.4% in the fourth quarter, but that compared unfavorably with ...